脂肪组织
内科学
随机对照试验
医学
生物信息学
信号转导
内分泌学
细胞生物学
生物
作者
Anne‐Sophie Wedell‐Neergaard,Louise Lang Lehrskov,Regitse Højgaard Christensen,Grit Elster Legaard,Emma Dorph,Monica Korsager Larsen,Natja Launbo,Sabrina Ravn Fagerlind,Sidsel Kofoed Seide,Stine Nymand,Maria Ball,Nicole Vinum,Camilla Noerfelt Dahl,Marie Henneberg,Mathias Ried‐Larsen,Janus Damm Nybing,Robin Christensen,Jaya B. Rosenmeier,Kristian Karstoft,Bente Klarlund Pedersen
出处
期刊:Cell Metabolism
[Cell Press]
日期:2018-12-27
卷期号:29 (4): 844-855.e3
被引量:322
标识
DOI:10.1016/j.cmet.2018.12.007
摘要
Visceral adipose tissue is harmful to metabolic health. Exercise training reduces visceral adipose tissue mass, but the underlying mechanisms are not known. Interleukin-6 (IL-6) stimulates lipolysis and is released from skeletal muscle during exercise. We hypothesized that exercise-induced reductions in visceral adipose tissue mass are mediated by IL-6. In this randomized placebo-controlled trial, we assigned abdominally obese adults to tocilizumab (IL-6 receptor antibody) or placebo during a 12-week intervention with either bicycle exercise or no exercise. While exercise reduced visceral adipose tissue mass, this effect of exercise was abolished in the presence of IL-6 blockade. Changes in body weight and total adipose tissue mass showed similar tendencies, whereas lean body mass did not differ between groups. Also, IL-6 blockade increased cholesterol levels, an effect not reversed by exercise. Thus, IL-6 is required for exercise to reduce visceral adipose tissue mass and emphasizes a potentially important metabolic consequence of IL-6 blockade.
科研通智能强力驱动
Strongly Powered by AbleSci AI